HAIXI PHARMA (02637) Announces New Board Appointments and Leadership Changes

Stock News05-27

HAIXI PHARMA (02637) has announced that Dr. Chen Shuyi and Mr. Gong Weimin have retired as directors of the board following the conclusion of the annual general meeting.

During the annual general meeting, Mr. Li Junqing was elected as an executive director, and Mr. Lin Bin was elected as an independent non-executive director. Their terms are for three years, effective from the end of the annual general meeting until the conclusion of the company's annual general meeting in 2029.

At a subsequent board meeting, the board elected Kang Xinshan as the chairman of the second-term board of directors for a three-year term, commencing from the date of the board meeting.

Additionally, the board appointed Kang Xinshan as the company's general manager. Other appointments include Ms. Feng Yan as deputy general manager, Dr. Chen Guangming as deputy general manager, Dr. Zhang Mingqiang as deputy general manager, and Ms. Zhang Junhuan as board secretary and chief financial officer.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1112742027?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-27 17:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1112742027","market":"nz","top_or_hot":-1,"title":"HAIXI PHARMA (02637) Announces New Board Appointments and Leadership Changes","media":"Stock News","content":"<p>HAIXI PHARMA (02637) has announced that Dr. Chen Shuyi and Mr. Gong Weimin have retired as directors of the board following the conclusion of the annual general meeting.</p>\n<p>During the annual general meeting, Mr. Li Junqing was elected as an executive director, and Mr. Lin Bin was elected as an independent non-executive director. Their terms are for three years, effective from the end of the annual general meeting until the conclusion of the company's annual general meeting in 2029.</p>\n<p>At a subsequent board meeting, the board elected Kang Xinshan as the chairman of the second-term board of directors for a three-year term, commencing from the date of the board meeting.</p>\n<p>Additionally, the board appointed Kang Xinshan as the company's general manager. Other appointments include Ms. Feng Yan as deputy general manager, Dr. Chen Guangming as deputy general manager, Dr. Zhang Mingqiang as deputy general manager, and Ms. Zhang Junhuan as board secretary and chief financial officer.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HAIXI PHARMA (02637) Announces New Board Appointments and Leadership Changes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHAIXI PHARMA (02637) Announces New Board Appointments and Leadership Changes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-27 17:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HAIXI PHARMA (02637) has announced that Dr. Chen Shuyi and Mr. Gong Weimin have retired as directors of the board following the conclusion of the annual general meeting.</p>\n<p>During the annual general meeting, Mr. Li Junqing was elected as an executive director, and Mr. Lin Bin was elected as an independent non-executive director. Their terms are for three years, effective from the end of the annual general meeting until the conclusion of the company's annual general meeting in 2029.</p>\n<p>At a subsequent board meeting, the board elected Kang Xinshan as the chairman of the second-term board of directors for a three-year term, commencing from the date of the board meeting.</p>\n<p>Additionally, the board appointed Kang Xinshan as the company's general manager. Other appointments include Ms. Feng Yan as deputy general manager, Dr. Chen Guangming as deputy general manager, Dr. Zhang Mingqiang as deputy general manager, and Ms. Zhang Junhuan as board secretary and chief financial officer.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"","article_id":"1112742027","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1112742027","pubTimestamp":1779874834,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"HAIXI PHARMA (02637) has announced that Dr. Chen Shuyi and Mr. Gong Weimin have retired as directors of the board following the conclusion of the annual general meeting. During the annual general...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1191":"制药","02637":"海西新药"},"translate_title":"海西药业(02637)公布新董事会委任及领导层变动","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02637":1},"content_text":"HAIXI PHARMA (02637) has announced that Dr. Chen Shuyi and Mr. Gong Weimin have retired as directors of the board following the conclusion of the annual general meeting.\nDuring the annual general meeting, Mr. Li Junqing was elected as an executive director, and Mr. Lin Bin was elected as an independent non-executive director. Their terms are for three years, effective from the end of the annual general meeting until the conclusion of the company's annual general meeting in 2029.\nAt a subsequent board meeting, the board elected Kang Xinshan as the chairman of the second-term board of directors for a three-year term, commencing from the date of the board meeting.\nAdditionally, the board appointed Kang Xinshan as the company's general manager. Other appointments include Ms. Feng Yan as deputy general manager, Dr. Chen Guangming as deputy general manager, Dr. Zhang Mingqiang as deputy general manager, and Ms. Zhang Junhuan as board secretary and chief financial officer.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1112742027","isCrawlerRequest":true}